| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc. | Chief Medical Officer | Common Stock | 43,210 | $1,626,857 | $37.65 | 17 Oct 2023 | Direct |
| Crinetics Pharmaceuticals, Inc. | Chief Medical Officer | Non-qualified stock option (Right to Buy) | 153,473 | 17 Oct 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRNX | Crinetics Pharmaceuticals, Inc. | 17 Oct 2023 | 3 | -$125,930 | 4 | Chief Medical Officer | 19 Oct 2023, 17:01 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 16 Mar 2023 | 1 | -$28,881 | 4 | Chief Medical Officer | 17 Mar 2023, 17:09 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 01 Mar 2023 | 2 | $0 | 4 | Chief Medical Officer | 03 Mar 2023, 15:43 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 31 Dec 2022 | 2 | +$21,236 | 5 | Chief Medical Officer | 27 Jan 2023, 15:28 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 28 Feb 2022 | 2 | $0 | 4 | Chief Medical Officer | 02 Mar 2022, 20:00 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 19 Jan 2022 | 3 | -$61,613 | 4 | Chief Medical Officer | 21 Jan 2022, 15:54 |